Back to catalogue
№ 191 35 filings · 2021-05-24 → 2026-05-01

MJ GLEESON PLC

GLE
Consumer Products and Services Share price 279p Market cap £163m Overall fit 220 /1000

Genuinely cheap with a solid balance sheet, but zero AI receiver exposure, only moderate operating leverage, and a track record of recent guidance cuts means it fails the strategy's primary AI/operating-leverage filters even though it passes the valuation-discipline and downside-protection filters.

Fair value range 285p–360p Mid case · £187m
Absolute upside +14.9% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Net assets 522p/share vs 221p price — discount anchored by real inventory at near-cost
  • Clean balance sheet with low gearing (net debt £22.5m vs £305m equity)
  • Detailed segmental disclosure allows NAV and earnings cross-check
Limits the call
  • New management continues to find legacy site issues — further provisions plausible
  • FY26 outcome hinges on a single large land sale contingent on highways approval
Methodology

Blended NAV (0.55-0.70x tangible book) and through-cycle P/E (~10x normalised EPS)

In one line · bull case

A balance-sheet-strong UK housebuilder trading at 0.42x NAV with self-help underway, where a multi-year earnings normalisation and partial NAV re-rating could deliver 30-60% upside without requiring a cyclical melt-up.

In one line · biggest risk

Continued discovery of legacy site liabilities by new management, combined with margin compression that prevents the earnings recovery the NAV-to-P&L bridge requires.

Drivers
AI beneficiary 5 /100
Affordable UK housebuilder with no AI mention or AI-driven revenue line in any filing.
Operating leverage 42 /100
Typical housebuilder mix — variable land/build costs dominate, ~£60m fixed admin base gives some drop-through but not multiplicative.
Earnings vs expectations 30 /100
Two of last three years involved mid-year guidance cuts; FY25 missed and FY26 includes c.£10m of newly disclosed legacy/restructuring charges.
Growth momentum 25 /100
Revenue grew 9.6% in H1 FY26 but operating profit fell 17.6%; PBT trajectory £55.5m → £30.5m → £24.9m → £21.9m → £18.2m consensus is decelerating.
Moat 25 /100
Low-cost affordable niche provides some positional advantage but no structural barrier; competition from larger housebuilders' value brands is real.
Earnings quality 38 /100
Recurring exceptional items (£12.9m building safety, £1.3m FY25 restructuring, £7-10m FY26 legacy & restructuring) cloud underlying earnings.
Management quality 48 /100
New CEO (Jan 2023, ex-Vistry) executing visible restructure but still surfacing legacy issues — track record yet to be established.
Cyclicality 80 /100
Deeply cyclical UK housebuilder exposed to mortgage rates, planning system and consumer confidence.
Leverage 18 /100
Net debt £22.5m vs £305m equity and £111m undrawn facility — fortress balance sheet by sector standards.
Value-trap signals · 4
  • Repeated guidance cuts (FY25 May 2025 cut; FY26 May 2026 added c.£10m exceptionals)
  • Declining underlying earnings across five-year period
  • Senior management departures and continued legacy-site discoveries
  • Gross margin compression Gleeson Homes (24.5% → 20.6% → 19.8% over three half-years)

MJ Gleeson PLC (GLE.L) — Investment Research Note

Executive summary

MJ Gleeson is a UK housebuilder (Gleeson Homes, low-cost affordable houses in the Midlands and North) paired with a Southern-focused strategic land-promotion arm (Gleeson Land). The trajectory across the period is one of sharp earnings de-rating: pre-tax profit fell from £55.5m in FY2022 to £20.5m in FY2025, with FY2026 consensus £18.2m and incremental £7-10m exceptional charges flagged for legacy-site rectification and restructuring 2026-05-01 trading update. The single most important point for valuation today is that at 221p the shares trade at ~0.42× the 522p NAV reported at 31 December 2025 — a discount that more than prices the cyclical and operational headwinds, but the catalyst path is unclear.

Fair value estimate

  • Fair value range: 285p – 360p per share
  • Implied market cap range: £166m – £210m
  • Mid-point: ~320p / £187m

Methodology: blended NAV / through-cycle earnings.

  • NAV anchor: net assets per share 522p at 31 Dec 2025 2026-02-11 H1 results. UK housebuilders trade 0.55–0.85× tangible NAV through cycles; the bulk of net assets is real inventory (£417m land + WIP) carried at cost with modest write-downs (~£7m NRV provision). Applying 0.55-0.70× yields 285–365p.
  • Earnings cross-check: FY2026 consensus £18.2m PBT 2026-05-01; through-cycle normalised PBT plausibly £25–35m on the 1,800–2,000 unit run-rate once Project Transform delivers and legacy provisions wash out. 10× normalised post-tax EPS of ~32p ≈ 320p.

Vs market cap of £145.0m: mid-point fair value implies ~+45% absolute upside (to 320p mid-point). At 285p low, upside ~29%; at 360p high, ~63%.

Sector context

Confirmed sector: Consumer Products and Services (ICB), within UK housebuilders. Note Gleeson sits awkwardly in "consumer products" — operationally it is a cyclical housebuilder.

Profile vs peers: below typical large-cap UK housebuilders on margin (FY2025 ROCE 7.6% vs Persimmon/Bellway double-digit), above on balance-sheet quality (low gearing, net debt £22.5m vs ~£305m equity), niche-defensive on positioning (sub-£200k ASP, exposure to first-time buyers on National Living Wage rather than help-to-buy-dependent £300k+ segment).

Listed peers: Vistry Group, Bellway, MJ Gleeson's land arm comparable to LSL/Gladman (private). Gleeson is closest in profile to small-cap Springfield Properties and the lower-margin end of Persimmon.

Investment thesis (3 bullets)

  1. NAV discount with real, conservatively-marked assets. Net assets per share 522p at 31 Dec 2025 sits behind a 221p share price — a 58% discount. Inventory is £417m of land and WIP carried near cost, with a modest £7.3m NRV provision 2026-02-11 H1 results. Net debt is only £22.5m on a £135m committed facility. Even a generous mark-down of land book gets to a defensible floor near current levels.

  2. Genuine self-help underway. Project Transform restructuring (new CEO Graham Prothero ex-Vistry, May 2025 management overhaul) targets £4.3m of annualised overhead savings (£1.1m phase 1 + £0.9m Yorkshire consolidation + previously delivered £3.2m) on a ~£60m admin base 2026-05-01 trading update, 2025-07-04 trading update. Forward order book at H1 was 978 plots up 64% YoY 2026-02-11, suggesting volume baseline is firm even if margin recovery is slow.

  3. Structurally undersupplied segment. Average Gleeson home £198,800 — affordable to a NLW couple, cheaper than equivalent rent 2026-02-11. Mortgage rates falling, NPPF reform supports planning. Gleeson Partnerships gives a "capital-light" growth lever via housing-association forward funding under the new £39bn Social and Affordable Homes Programme 2026-02-11.

Key risks (3 bullets)

  1. Legacy-site provisions show governance weakness, magnitude uncertain. New management has flagged £5.2–7.1m provisions for rectification of historic Yorkshire developments, on top of £4.5m restructuring and £3.1m impairment, all to be excluded from "adjusted" results 2026-05-01. Combined with the still-undrawn £11.7m building-safety provision, this is the second wave of legacy issues discovered since the new CEO arrived. Further skeletons cannot be ruled out.

  2. Cyclical, with margin compression unresolved. Gleeson Homes gross margin fell from 24.5% (H1 24) → 20.6% (H1 25) → 19.8% (H1 26) 2026-02-11. Build cost inflation 2.6% is outpacing net selling-price increases of 1.7%; bulk-sale discounts and elevated 4.5% incentives are compressing margins further. Spring selling season is "fundamental" to FY2026 delivery and softness has been noted post the Middle East disruption 2026-05-01.

  3. Zero AI receiver exposure (inferred). The filings make no AI references; the business is bricks-and-mortar housebuilding with land promotion. For an AI-receiver mandate this is structurally off-thesis — incremental AI capex in the economy could even be a mild headwind via labour/materials competition.

Operating leverage

This is a moderately operating-levered housebuilder, not the high-fixed-cost software model the buyer wants. Cost structure: roughly 80% of cost-of-sales is variable land + build cost; the ~£60m of group admin (£30.9m H1 2026 + £2.1m central) is largely fixed and represents ~9% of revenue 2026-02-11. At current scale, an incremental £20m of revenue at 20% gross margin and ~£0.5m of incremental admin would convert to ~£3.5m of operating profit — roughly an 80% incremental EBIT margin on the contribution-margin layer, but the gross margin layer caps the absolute leverage. A 10–20% revenue beat from a market recovery would plausibly add 30–60% to operating profit, lifting it back toward the FY2022 peak. The inflection points to watch are (a) gross margin recovery as higher-priced new sites open and bulk-sale mix falls, and (b) operating-leverage drop-through from the c.£4.3m of annualised admin savings. This is operating-leverage score ~45 territory — meaningful but not the multiplicative software-style leverage.

Value-trap signals

  • Repeated guidance cuts: June 2025 trading update flagged Gleeson Homes operating profit 15–20% below market expectations following a land-disposal that did not proceed 2025-06-03. Further FY2025 trading update July 2025 flagged Gleeson Land at lower end of range 2025-07-04. May 2026 trading update added c.£10m of exceptional and legacy charges 2026-05-01.
  • Declining earnings trend across the period: PBT £55.5m (FY22) → £30.5m → £24.9m → £21.9m → £18.2m consensus (FY26).
  • CEO change + senior departures: Mark Knight (Homes CEO) departed July 2025; replaced by external hires 2025-07-04. New CEO continues to find legacy issues — pattern suggests prior controls weak.
  • Net assets per share has stopped growing: 522p at Dec 2025 vs 508p Dec 2024 — modest growth, dividend partly funded from cash.

These do not collectively read as terminal decline (the business is balance-sheet sound, demand structurally exists), but they argue against treating this as a temporary mispricing.

Earnings vs expectations

Pattern: more misses than beats in the recent past, but stabilising into FY26.

  • FY2022 (Sep-22): "significantly ahead of expectations" — record £55.5m PBT 2022-07-11 trading update.
  • FY2023: guided "in line" Mar-23, delivered £30.5m PBT in line with downgraded expectations.
  • FY2024 (Jul-24): met market expectations on volumes (1,772 homes), Gleeson Land missed (£2m vs £7-8m range).
  • FY2025: MISS — June 2025 guidance cut to 15–20% below Homes expectations; full-year PBT ex-exceptional £21.9m, at lower end after cut.
  • H1 FY2026: in line with downgraded expectations; FY26 guidance reiterated at £18.2m consensus midpoint 2026-05-01.

Summary: two of last three years involved material guidance cuts. The trend is downgrades-then-meet-the-downgrade.

Conviction

Conviction: 3 (moderate)

Anchors: (a) NAV cushion is real and disclosed in detail, (b) balance sheet is unambiguous (£22.5m net debt vs £305m equity, £111m undrawn facility), (c) demand drivers and product-affordability metrics are well-documented across multiple filings.

Caveats: (a) ongoing discovery of legacy site issues by new management — the c.£10m of new provisions at H2 2026 weren't visible at H1 results, and a third wave is plausible; (b) FY2026 hinges on a single ~50% land-sale completion at Gleeson Land contingent on highways approval — binary timing risk.


Driver scoring summary

  • AI receiver exposure: essentially none.
  • Operating leverage: moderate — typical housebuilder.
  • Valuation: clearly cheap on NAV, fair on through-cycle earnings.
  • Quality / downside: above-average balance sheet, below-average earnings consistency.

Overall fit with this investor's strategy: low. The valuation discount is real and the balance sheet provides downside protection, but the absence of AI-receiver characteristics and only-moderate operating leverage means it does not fit the core thesis.

Filings consulted · 41

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-05-01Trading Update2026-05-01_9547950_trading-update.md0.85
  2. 2026-04-23Notice OF Trading Updates And Fy2026 Results2026-04-23_9533782_notice-of-trading-updates-and-fy2026-results.md0.85
  3. 2026-02-11Results For The Half Year Ended 31 December 20252026-02-11_9424662_results-for-the-half-year-ended-31-december-2025.md0.90
  4. 2026-02-09Presentation OF HY Results ON Engage Investor2026-02-09_9420133_presentation-of-hy-results-on-engage-investor.md0.70
  5. 2026-01-16Trading Update And Notice OF Results2026-01-16_9357547_trading-update-and-notice-of-results.md0.85
  6. 2025-11-14Result OF Agm2025-11-14_9234857_result-of-agm.md0.26
  7. 2025-11-14Agm Trading Update2025-11-14_9232963_agm-trading-update.md0.72
  8. 2025-10-17Notice OF Agm2025-10-17_9176892_notice-of-agm.md0.26
  9. 2025-09-18Presentation ON Engage Investor Platform2025-09-18_9115280_presentation-on-engage-investor-platform.md0.59
  10. 2025-08-13Notice OF Full Year Results And Presentation2025-08-13_9048706_notice-of-full-year-results-and-presentation.md0.85
  11. 2025-07-04Trading Statement2025-07-04_8963343_trading-statement.md0.72
  12. 2025-06-03Trading Update2025-06-03_8909032_trading-update.md0.55
  13. 2025-02-11Results For The Half Year Ended 31 December 20242025-02-11_8730268_results-for-the-half-year-ended-31-december-2024.md0.58
  14. 2025-01-14Trading Update Amp Notice OF Results2025-01-14_8686459_trading-update-amp-notice-of-results.md0.55
  15. 2024-11-15Result OF Agm2024-11-15_8553464_result-of-agm.md0.20
  16. 2024-11-15Agm Trading Update2024-11-15_8551567_agm-trading-update.md0.55
  17. 2024-10-21Notice OF Agm2024-10-21_8497381_notice-of-agm.md0.20
  18. 2024-07-11Fy2024 Trading Update2024-07-11_8305222_fy2024-trading-update.md0.55
  19. 2024-07-08Notice OF Trading Update2024-07-08_8298019_notice-of-trading-update.md0.55
  20. 2024-02-15Results For The Half Year Ended 31 December 20232024-02-15_8038807_results-for-the-half-year-ended-31-december-2023.md0.41
  21. 2024-01-09Trading Update Amp Notice OF Results2024-01-09_7980186_trading-update-amp-notice-of-results.md0.38
  22. 2023-11-16Result OF Agm2023-11-16_7886137_result-of-agm.md0.14
  23. 2023-11-16Agm Trading Update2023-11-16_7884397_agm-trading-update.md0.38
  24. 2023-10-17Notice OF Agm2023-10-17_7820356_notice-of-agm.md0.14
  25. 2023-07-07Trading Update And Capital Markets Day2023-07-07_7618152_trading-update-and-capital-markets-day.md0.43
  26. 2023-03-21Notice OF Capital Markets Day And Trading Update2023-03-21_7479853_notice-of-capital-markets-day-and-trading-update.md0.24
  27. 2023-02-16Results For The Half Year Ended 31 December 20222023-02-16_7482090_results-for-the-half-year-ended-31-december-2022.md0.23
  28. 2023-01-13Trading Update Amp Notice OF Results2023-01-13_7399280_trading-update-amp-notice-of-results.md0.21
  29. 2022-11-18Result OF Agm2022-11-18_7417629_result-of-agm.md0.07
  30. 2022-11-18Agm Trading Update2022-11-18_7414752_agm-trading-update.md0.21
  31. 2022-10-20Notice OF Agm2022-10-20_7385256_notice-of-agm.md0.07
  32. 2022-09-15Final Results2022-09-15_7316190_final-results.md0.25
  33. 2022-07-11Trading Update Amp Notice OF Results2022-07-11_6923332_trading-update-amp-notice-of-results.md0.21
  34. 2022-05-12Notice OF Trading Update Amp Results2022-05-12_7275067_notice-of-trading-update-amp-results.md0.21
  35. 2022-02-10Half Year Report2022-02-10_6800446_half-year-report.md0.23
  36. 2022-01-11Notice OF Results Amp Trading Update2022-01-11_6807772_notice-of-results-amp-trading-update.md0.21
  37. 2021-11-15Result OF Agm2021-11-15_6738878_result-of-agm.md0.07
  38. 2021-11-15Agm Statement2021-11-15_6737702_agm-statement.md0.10
  39. 2021-10-13Notice OF Agm2021-10-13_6768774_notice-of-agm.md0.07
  40. 2021-07-09Notice OF Results Amp Trading Update2021-07-09_6552057_notice-of-results-amp-trading-update.md0.21
  41. 2021-05-24Trading Update2021-05-24_6480901_trading-update.md0.09

This research note was authored by a large language model after reading 35 regulatory filings published between 2021-05-24 and 2026-05-01. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.